Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis.

Escribano BM, Aguilar M, Bahamonde C, Conde C, Lillo R, Sánchez-López F, Giraldo AI, Cruz AH, Luque E, Gascón F, et al.